Gateway Investment Advisers LLC Alnylam Pharmaceuticals, Inc. Transaction History

Gateway Investment Advisers LLC

$9 Billion
Q3 2024

A detailed history of Gateway Investment Advisers LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Gateway Investment Advisers LLC holds 6,161 shares of ALNY stock, worth $1.45 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

6,161

Previous 6,677 7.73%

Holding current value

$1.45 Million

Previous $1.62 Million 4.44%

% of portfolio

0.02%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$233.81 - $287.01 $120,645 - $148,097	-516 Reduced 7.73%	6,161 $1.69 Million
Q2 2024 Jul 12, 2024	SELL	$143.31 - $247.0 $1.77 Million - $3.05 Million	-12,360 Reduced 64.93%	6,677 $1.62 Million
Q1 2024 Apr 12, 2024	BUY	$146.51 - $198.2 $879 - $1,189	6 Added 0.03%	19,037 $2.85 Million
Q4 2023 Jan 09, 2024	BUY	$151.41 - $196.57 $769,162 - $998,575	5,080 Added 36.41%	19,031 $3.64 Million
Q3 2023 Oct 19, 2023	BUY	$170.77 - $211.65 $408,652 - $506,478	2,393 Added 20.7%	13,951 $2.47 Million
Q2 2023 Jul 13, 2023	BUY	$185.01 - $212.05 $89,914 - $103,056	486 Added 4.39%	11,558 $2.2 Million
Q1 2023 Apr 11, 2023	SELL	$182.66 - $235.53 $23,563 - $30,383	-129 Reduced 1.15%	11,072 $2.22 Million
Q4 2022 Jan 13, 2023	BUY	$185.53 - $241.31 $48,237 - $62,740	260 Added 2.38%	11,201 $0
Q3 2022 Oct 07, 2022	SELL	$138.54 - $232.0 $2.12 Million - $3.56 Million	-15,324 Reduced 58.34%	10,941 $2.19 Million
Q2 2022 Jul 13, 2022	BUY	$120.42 - $169.29 $3,130 - $4,401	26 Added 0.1%	26,265 $3.83 Million
Q1 2022 Apr 14, 2022	BUY	$127.18 - $173.91 $2.76 Million - $3.77 Million	21,671 Added 474.41%	26,239 $4.29 Million
Q4 2021 Jan 14, 2022	SELL	$159.56 - $209.29 $957 - $1,255	-6 Reduced 0.13%	4,568 $775,000
Q3 2021 Oct 22, 2021	BUY	$169.75 - $207.73 $56,017 - $68,550	330 Added 7.78%	4,574 $864,000
Q1 2021 Apr 14, 2021	BUY	$126.83 - $175.69 $1,268 - $1,756	10 Added 0.24%	4,244 $599,000
Q4 2020 Jan 14, 2021	BUY	$122.97 - $147.0 $9,468 - $11,319	77 Added 1.85%	4,234 $550,000
Q3 2020 Oct 19, 2020	SELL	$121.19 - $165.49 $7,513 - $10,260	-62 Reduced 1.47%	4,157 $605,000
Q1 2020 Apr 13, 2020	SELL	$93.12 - $133.99 $93 - $133	-1 Reduced 0.02%	4,219 $459,000
Q4 2019 Jan 09, 2020	SELL	$74.51 - $124.23 $7,227 - $12,050	-97 Reduced 2.25%	4,220 $486,000
Q3 2019 Oct 15, 2019	SELL	$70.9 - $87.82 $212 - $263	-3 Reduced 0.07%	4,317 $347,000
Q1 2019 Apr 10, 2019	SELL	$72.76 - $93.45 $15,352 - $19,717	-211 Reduced 4.66%	4,320 $404,000
Q4 2018 Jan 14, 2019	BUY	$62.67 - $88.33 $41,800 - $58,916	667 Added 17.26%	4,531 $330,000
Q2 2018 Jul 11, 2018	SELL	$88.31 - $107.8 $3,267 - $3,988	-37 Reduced 0.95%	3,864 $381,000
Q1 2018 Apr 12, 2018	BUY	$115.92 - $148.54 $38,253 - $49,018	330 Added 9.24%	3,901 $465,000
Q4 2017 Jan 17, 2018	BUY	$114.49 - $139.98 $408,843 - $499,868	3,571	3,571 $454,000

Others Institutions Holding ALNY

# of Institutions

641

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $29B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gateway Investment Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gateway Investment Advisers LLC with notifications on news.

Account

Gateway Investment Advisers LLC Alnylam Pharmaceuticals, Inc. Transaction History